Trial Phase | Target Proteins | Vaccine Vectors | Inoculation | Target Types |
---|---|---|---|---|
Ph-I/II [27] | L1, E7 | Chimera-VLP | S.C. | 16 |
Ph-II [26] | E7 | Hsp (SGN-00101] | S.C. | 16 |
Ph-II [28] | E6, E7 | Vaccinia virus (TA-HPV) | I.M. | 16, 18 |
Ph-II [29] | L2, E6, E7 | Fusion protein L2E6E7 (TA-CIN) | I.M. | 16, 18 |
Ph-II [30] | BPV E2 | Vaccinia virus (MVA-E2] | intrauteral | all |
Ph-III [31] | E6, E7 | plasmid vaccine (ZYC101a) | I.M. | 16, 18 |
Ph-II [32] | E6, E7 | Cocktailed Synthetic peptide | S.C. | 16 |